Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials | Zendy

Will Garner | Zendy; Kirsten L. White | Zendy; Javier Szwarcberg | Zendy; Scott McCallister | Zendy; Lijie Zhong | Zendy; Mike Wulfsohn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials

Author(s) -

Will Garner,

Kirsten L. White,

Javier Szwarcberg,

Scott McCallister,

Lijie Zhong,

Mike Wulfsohn

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ1034

Subject(s) - concordance , taqman , medicine , virology , human immunodeficiency virus (hiv) , viral load , lentivirus , rna , real time polymerase chain reaction , viral disease , biology , gene , biochemistry

The COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (Amplicor) has been replaced with the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, version 2.0 (TaqMan 2.0), a real-time polymerase chain reaction human immunodeficiency virus type 1 (HIV-1) assay with higher sensitivity and broader dynamic range. HIV-1 RNA values at the 50 copies/mL cutoff drive major patient management decisions and clinical study outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research